Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
  • Register or Login
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Amy Karon

News

Revision total joint replacements linked to higher infection risk

Author:
Amy Karon
Publish date: May 24, 2019

The 90-day risk of surgical site infection was 5.77 times higher after revision vs. primary total joint replacement.

  • Read More

News

TEG-guided topped conventional transfusion in cirrhotic patients with variceal bleeding

Author:
Amy Karon
Publish date: May 23, 2019

With TEG, only four (13.3%) patients received transfusions, compared with every patient in the conventional transfusion group (P less...

  • Read More

News

Zoster vaccination is underused but looks effective in IBD

Author:
Amy Karon
Publish date: May 22, 2019

For men with inflammatory bowel disease, herpes zoster vaccination was associated with about a 46% decrease in risk of associated infection...

  • Read More

News

BMI in male teens predicts cardiomyopathy risk

Author:
Amy Karon
Publish date: May 20, 2019

The hazard ratio for dilated cardiomyopathy in adulthood was 1.38 when adolescent body mass index was 22.5-25.0 kg/m2 – and rose to 8....

  • Read More

News

Pancreatic cancers often contained targetable mutations

Author:
Amy Karon
Publish date: May 15, 2019

A total of 17% of specimens harbored mutations that are potentially targetable with existing therapies. These mutations involved either RTK/ras/...

  • Read More

News

Infections within first year of life predicted IBD

Author:
Amy Karon
Publish date: May 15, 2019

The correlation was strongest for onset by age 10 years.

  • Read More

News

Induction trough levels predicted ustekinumab response in Crohn’s disease

Author:
Amy Karon
Publish date: May 8, 2019

An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of...

  • Read More

News

Clock gene disruption might underlie IBD

Author:
Amy Karon
Publish date: May 8, 2019

Multiple clock genes showed reduced mRNA expression in inflamed and uninflamed intestinal mucosa and peripheral white blood cells from patients,...

  • Read More

News

AGA Clinical Practice Update: Direct-acting antivirals and hepatocellular carcinoma

Author:
Amy Karon
Publish date: May 8, 2019

For patients listed for liver transplantation, determine timing of DAA therapy on a case-by-case basis, consider regional wait times, availability...

  • Read More

News

Ulipristal acetate tops placebo for uterine leiomyomas

Author:
Amy Karon
Publish date: May 1, 2019

Significantly greater improvements in physical and social activities were seen with both ulipristal doses, compared with placebo, from baseline to...

  • Read More

News

Study compares tapering strategies in rheumatoid arthritis

Author:
Amy Karon
Publish date: May 1, 2019

Cumulative rates of flare at 1 year were 33% with initial tapering of conventional synthetic DMARDs and 43% with initial TNF-inhibitor tapering (...

  • Read More

News

Induction trough levels predicted ustekinumab response in Crohn’s disease

Author:
Amy Karon
Publish date: May 1, 2019

An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of...

  • Read More

News

Tailoring the Mediterranean diet for NAFLD

Author:
Amy Karon
Publish date: April 30, 2019

Keys to success included providing recipes and meal planners, education on how lifestyle and diet contribute to NAFLD, and offering care in person...

  • Read More

News

Positive psoriatic arthritis screens occur often in psoriasis patients

Author:
Amy Karon
Publish date: April 30, 2019

In all, 12.4% of patients had a positive screen for possibly undiagnosed psoriatic arthritis but had never been diagnosed with the disease.

  • Read More

News

Gene therapy restored immunity in newly diagnosed SCID-X1

Author:
Amy Karon
Publish date: April 23, 2019

In the phase 1/2 study, seven infants had normal immune cells 3-4 months after treatment, while the eighth infant responded after a gene therapy...

  • Read More

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2019 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.

click me
Menu Close
Register or Login